Löscher W, Böhme G, Müller F, Pagliusi S
J Neurochem. 1985 Sep;45(3):879-89. doi: 10.1111/j.1471-4159.1985.tb04076.x.
A procedure is described for the rapid preparation of nerve ending particles (synaptosomes) from 11 regions of one rat brain. The synaptosomal fractions have been characterized by electron microscopy and determination of four marker enzymes, i.e., glutamate decarboxylase (GAD), acetylcholinesterase, succinate dehydrogenase, and glycerol 3-phosphate dehydrogenase. Comparison with a much lengthier standard (Ficoll-sucrose) preparation showed that the synaptosomal yield of the new procedure was substantially better as judged by both morphological evaluation and protein recovery. The improved synaptosome preparation was used for determination of regional gamma-aminobutyric acid (GABA) levels in synaptosomal fractions. The postmortem increase in GABA level during removal and dissection of brain tissue and homogenization and fractionation procedures could be minimized by rapid processing of the tissue at low temperatures and inclusion of the GAD inhibitor 3-mercaptopropionic acid (3-MP; 1 mM) in the homogenizing medium. The addition of GABA (0.2 mM) to the homogenizing medium did not alter the GABA levels in the synaptosomes, indicating that no significant redistribution of GABA occurred during subcellular fractionation in sodium-free media. Synaptosomal GABA levels determined in the 11 rat brain areas showed the same regional distribution as the GABA-synthesizing enzyme GAD. On the basis of these findings, it was suggested that the synaptosome preparation could be used to evaluate the in vivo effects of drugs on nerve terminal GABA. Treatment of rats with a convulsant dose of 3-MP (50 mg/kg i.p.) 3 min before decapitation significantly lowered synaptosomal GABA levels in olfactory bulb, hippocampus, thalamus, tectum, and cerebellum. The 3-MP-induced seizures and reduction of GABA levels could be prevented by administration of valproic acid (200 mg/kg i.p.) 15 min before the 3-MP injection. The data indicate that the improved synaptosome preparation offers a convenient method of preparing highly purified synaptosomes from a large number of small tissue samples and can provide useful information on the in vivo effects of drugs on regional GABA levels in nerve terminals.
本文描述了一种从一只大鼠大脑的11个区域快速制备神经末梢颗粒(突触体)的方法。通过电子显微镜和四种标记酶(即谷氨酸脱羧酶(GAD)、乙酰胆碱酯酶、琥珀酸脱氢酶和甘油3 - 磷酸脱氢酶)的测定对突触体组分进行了表征。与一种长得多的标准(Ficoll - 蔗糖)制备方法相比,从形态学评估和蛋白质回收率来看,新方法的突触体产量都有显著提高。改进后的突触体制备方法用于测定突触体组分中各区域γ - 氨基丁酸(GABA)的水平。在去除和解剖脑组织以及匀浆和分级分离过程中,通过在低温下快速处理组织并在匀浆介质中加入GAD抑制剂3 - 巯基丙酸(3 - MP;1 mM),可以将死后GABA水平的升高降至最低。向匀浆介质中添加GABA(0.2 mM)不会改变突触体中的GABA水平,这表明在无钠介质的亚细胞分级分离过程中GABA没有发生显著的重新分布。在11个大鼠脑区测定的突触体GABA水平显示出与GABA合成酶GAD相同的区域分布。基于这些发现,有人提出突触体制备方法可用于评估药物对神经末梢GABA的体内作用。在断头前3分钟给大鼠腹腔注射惊厥剂量的3 - MP(50 mg/kg)可显著降低嗅球、海马、丘脑、顶盖和小脑中突触体的GABA水平。在注射3 - MP前15分钟腹腔注射丙戊酸(200 mg/kg)可预防3 - MP诱导的癫痫发作和GABA水平降低。数据表明,改进后的突触体制备方法提供了一种从大量小组织样本中制备高度纯化突触体的便捷方法,并且可以提供有关药物对神经末梢区域GABA水平体内作用的有用信息。